Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 49

1.
2.

A systematic review of the clinical effectiveness of pioglitazone in the treatment of type 2 diabetes mellitus.

Chilcott J, Tappenden P, Jones ML, Wight JP.

Clin Ther. 2001 Nov;23(11):1792-823; discussion 1791. Review.

PMID:
11768834
4.

[Combination therapy of insulin sensitizer and sulfonylurea].

Hari J.

Nihon Rinsho. 1997 Nov;55 Suppl:197-203. Review. Japanese. No abstract available.

PMID:
9434467
5.

The role of pioglitazone in modifying the atherogenic lipoprotein profile.

Hanefeld M.

Diabetes Obes Metab. 2009 Aug;11(8):742-56. doi: 10.1111/j.1463-1326.2009.01048.x. Epub 2009 Jun 10. Review.

PMID:
19519869
6.

Effects on lipid profile of dipeptidyl peptidase 4 inhibitors, pioglitazone, acarbose, and sulfonylureas: meta-analysis of placebo-controlled trials.

Monami M, Vitale V, Ambrosio ML, Bartoli N, Toffanello G, Ragghianti B, Monami F, Marchionni N, Mannucci E.

Adv Ther. 2012 Sep;29(9):736-46. doi: 10.1007/s12325-012-0045-5. Epub 2012 Aug 24. Review.

PMID:
22923161
7.

Pioglitazone.

Gillies PS, Dunn CJ.

Drugs. 2000 Aug;60(2):333-43; discussion 344-5. Review.

PMID:
10983737
8.

[Rosiglitazone (BRL-49653)].

Kameda N, Okuya S, Oka Y.

Nihon Rinsho. 2000 Feb;58(2):401-4. Review. Japanese.

PMID:
10707565
10.

Combination insulin-sulfonylurea therapy.

Lebovitz HE, Pasmantier R.

Diabetes Care. 1990 Jun;13(6):667-75. Review.

PMID:
2192850
11.

Cinnamon use in type 2 diabetes: an updated systematic review and meta-analysis.

Allen RW, Schwartzman E, Baker WL, Coleman CI, Phung OJ.

Ann Fam Med. 2013 Sep-Oct;11(5):452-9. doi: 10.1370/afm.1517. Review.

12.

Fish oil supplementation in type 2 diabetes: a quantitative systematic review.

Montori VM, Farmer A, Wollan PC, Dinneen SF.

Diabetes Care. 2000 Sep;23(9):1407-15. Review.

13.

Treatment of diabetes mellitus: implications of the use of oral agents.

Rao SV, Bethel MA, Feinglos MN.

Am Heart J. 1999 Nov;138(5 Pt 1):S334-7. Review. No abstract available.

PMID:
10539794
14.

Meta-analysis of the effect of herbal supplement on glycemic control in type 2 diabetes.

Suksomboon N, Poolsup N, Boonkaew S, Suthisisang CC.

J Ethnopharmacol. 2011 Oct 11;137(3):1328-33. doi: 10.1016/j.jep.2011.07.059. Epub 2011 Aug 5. Review.

PMID:
21843614
15.

PROactive 07: pioglitazone in the treatment of type 2 diabetes: results of the PROactive study.

Erdmann E, Dormandy J, Wilcox R, Massi-Benedetti M, Charbonnel B.

Vasc Health Risk Manag. 2007;3(4):355-70. Review.

16.

A review of pioglitazone HCL and glimepiride in the treatment of type 2 diabetes.

Dorkhan M, Frid A.

Vasc Health Risk Manag. 2007;3(5):721-31. Review.

17.

Thiazolidinediones and liver toxicity.

Scheen AJ.

Diabetes Metab. 2001 Jun;27(3):305-13. Review.

18.

[Delayed sulfonylurea resistance in non-insulin-dependent diabetes mellitus].

Farkas K, Jermendy G, Somogyi A.

Orv Hetil. 1997 Nov 30;138(48):3031-5. Review. Hungarian.

PMID:
9441264
19.
20.

Combination sulfonylurea and insulin therapy in non-insulin-dependent diabetes mellitus.

Collo MB, Johnson JL, Kabadi UM.

Nurse Pract. 1993 Jul;18(7):40, 43-4, 47-8. Review.

PMID:
8351085

Supplemental Content

Support Center